Starke Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus
May 16, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Allschwil, 16. Mai 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
May 16, 2024 01:15 ET
|
Basilea Pharmaceutica AG
Allschwil, Switzerland, May 16, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...
Aegon appoints Duncan Russell to succeed Matt Rider as Chief Financial Officer
May 16, 2024 01:02 ET
|
Aegon Ltd.
The Hague, May 16, 2024 - Aegon today announces the appointment of Duncan Russell (1978) as Chief Financial Officer (CFO), effective September 1, 2024. Duncan will succeed Matt Rider (1963), who will...
Vastned Belgium: Toepassing van artikel 7:97 WVV door de raad van bestuur van Vastned Belgium
May 16, 2024 01:01 ET
|
Vastned Belgium NV
De raad van bestuur van Vastned Belgium NV (Euronext: VASTB, ‘Vastned Belgium’ of de ‘Vennootschap’) heeft het comité van onafhankelijke bestuurders van de Vennootschap (het ‘Comité’) verzocht om een...
Vastned Belgium: Application of article 7:97 BCAC by the Board of Directors of Vastned Belgium
May 16, 2024 01:01 ET
|
Vastned Belgium NV
The board of directors of Vastned Belgium NV (Euronext: VASTB, “Vastned Belgium” or the “Company”) has requested the committee of independent directors of the Company (the “Committee”) to issue an...
Vastned Belgium: Application of article 7:97 BCAC by the Board of Directors of Vastned Belgium
May 16, 2024 01:01 ET
|
Vastned Belgium
The board of directors of Vastned Belgium NV (Euronext: VASTB, “Vastned Belgium” or the “Company”) has requested the committee of independent directors of the Company (the “Committee”) to issue an...
KBC Groupe: Bénéfice de 506 millions d'euros pour le premier trimestre
May 16, 2024 01:00 ET
|
KBC Groep
‘Nous avons enregistré un bénéfice net de 506 millions d’euros au premier trimestre 2024. Par rapport au résultat du trimestre précédent, nos revenus totaux ont bénéficié de plusieurs facteurs,...
KBC Groep: Resultaat eerste kwartaal van 506 miljoen euro
May 16, 2024 01:00 ET
|
KBC Groep
"We boekten een nettowinst van 506 miljoen euro in het eerste kwartaal van 2024. Vergeleken met het resultaat van het vorige kwartaal profiteerden onze totale opbrengsten van verschillende factoren,...
Lassila & Tikanoja plans to accelerate strategy execution and renews its Group Executive Board
May 16, 2024 01:00 ET
|
Lassila & Tikanoja plc
Lassila & Tikanoja plc Stock exchange release 16 May 2024 at 8.00 a.m. Lassila & Tikanoja plans to accelerate strategy execution and renews its Group Executive Board Lassila & Tikanoja...
Zealand Pharma Announces Financial Results for the First Quarter of 2024
May 16, 2024 01:00 ET
|
Zealand Pharma
Company announcement - No. 26 / 2024 Zealand Pharma Announces Financial Results for the First Quarter of 2024 Strong performance in the first quarter of 2024 paving the way for important data...